Merck & Company, Inc. ( MRK ) will begin trading ex-dividend on March 14, 2018. A cash dividend payment of $0.48 per share is scheduled to be paid on April 06, 2018. Shareholders who purchased MRK prior to the ex-dividend date are eligible for the cash dividend payment. This represents an 2.13% increase over prior dividend payment.
The previous trading day's last sale of MRK was $55.36, representing a -16.64% decrease from the 52 week high of $66.41 and a 4.22% increase over the 52 week low of $53.12.
MRK is a part of the Health Care sector, which includes companies such as Johnson & Johnson ( JNJ ) and TiGenix ( TIG ). MRK's current earnings per share, an indicator of a company's profitability, is $.93. Zacks Investment Research reports MRK's forecasted earnings growth in 2018 as 4.4%, compared to an industry average of 9.7%.
Interested in gaining exposure to MRK through an Exchange Traded Fund [ETF]?
The following ETF(s) have MRK as a top-10 holding:
- iShares U.S. Healthcare ETF ( IYH )
- Vanguard Health Care ETF ( VHT )
- iShares Global Healthcare ETF ( IXJ )
- John Hancock Multifactor Healthcare ETF ( JHMH )
- Cambria Core Equity ETF ( CCOR ).
The top-performing ETF of this group is JHMH with an increase of 7.53% over the last 100 days. IYH has the highest percent weighting of MRK at 4.41%.